Sp1 and Sp3 activate transcription of the human dopamine transporter gene

Journal of Neurochemistry

Volumn 93, Issue 2, 2005, Pages 474-482

  Wang, Jun ^a   Bannon, Michael J ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine transporter; GC box; Promoter; SK N AS; Specificity protein 1; Specificity protein 3

Indexed keywords

DOPAMINE TRANSPORTER; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3;

ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DROSOPHILA; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MUTANT; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; CELL LINE; CELL LINE, TUMOR; DNA-BINDING PROTEINS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DROSOPHILA MELANOGASTER; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 17444398973     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03051.x     Document Type: Article

References (23)

1. Ammanamanchi S., Freeman J. W. and Brattain M. G. (2003) Acetylated Sp3 is a transcriptional activator. J. Biol. Chem. 278, 35 775-35 780.
2. Andrews N. C. and Faller D. V. (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19, 2499.
3. Bannon M. J. (2004) Dopamine, in Nature Encyclopedia of Life Sciences Nature Publishing Group, London. Available from: http://www.els.net
4. Bannon M. J., Michelhaugh S. K., Wang J. and Sacchetti P. (2001) The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders. Eur. Neuropsychopharmacol. 11, 449-455.
5. Bouwman P. and Philipsen S. (2002) Regulation of the activity of Sp1-related transcription factors. Mol. Cell Endocrinol. 195, 27-38.
6. Chadjichristos C., Ghayor C., Herrouin J. F., Ala-Kokko L., Suske G., Pujol J. P. and Galera P. (2002) Down-regulation of human type II collagen gene expression by transforming growth factor-β1 (TGF-β1) in articular chondrocytes involves Sp3/Sp1 ratio. J. Bio. Chem. 15, 43 903-43 917.
7. Dennig J., Beato M. and Suske G. (1996) An inhibitor domain in Sp3 regulates its glutamine-rich activation domains. EMBO J. 15, 5659-5667.
8. Doetzlhofer A., Rotheneder H., Lagger G., Koranda M., Kurtev V., Brosch G., Wintersberger E. and Seiger C. (1999) Histone deactylase 1 can repress transcription by binding to Sp1. Mol. Cell Biol. 19, 5504-5511.
9. Dynan W. S. and Tjian R. (1983) The promoter-specific transcription factor Sp1 binds to upstream sequences in SV40 early promoter. Cell 35, 79-87.
10. Imam S. Z., Duhart H. M., Skinner J. T. and Ali S. F. (2003) Cocaine induces a dose-dependent alteration in the expression of immediate early genes c-fos and Sp-1 and in nuclear factor NF-κβ in PC12 cells. Ann. NY Acad. Sci. 993, 387-393.
11. Kaczynski J., Cook T. and Urrutia R. (2003) Sp1- and Kruppel-like transcription factors. Genome Biol. 4, 206.
12. Kapatos G., Stegenga S. L. and Hirayama K. (2000) Identification and characterization of basal and cyclic AMP response elements in the promoter of the rat GTP cyclohydrolase I gene. J. Biol. Chem. 275, 5947-5957.
13. Kennett S. B., Udvadia A. J. and Horowitz J. M. (1997) Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription. Nucleic Acids Res. 25, 3110-3117.
14. Kouzmenko A. P., Pereira A. M. and Singh B. S. (1997) Intronic sequences are involved in neural targeting of human dopamine transporter gene expression. Biochem. Biophys. Res. Commun. 240, 807-811.
15. Liu A., Zhuang Z., Huffman P. W. and Bai G. (2003) Functional analysis of the rat N-methyl-D-aspartate receptor 2A promoter, multiple transcription starts points, positive regulation by Sp factors, and translational regulation. J. Biol. Chem. 278, 26 423-26 434.
16. Pang R. T., Lee L. T., Ng S. S., Yung W. H. and Chow B. K. (2004) CpG methylation and transcription factors Sp1 and Sp3 regulate the expression of the human secretin receptor gene. Mol. Endocrinol. 18, 471-483.
17. Ryu H., Lee J., Zaman K., Kubilis J., Ferrante R. J., Ross B. D., Neve R. and Ratan R. R. (2003) Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons. J. Neurosci. 23, 3597-3606.
18. Sacchetti P., Brownschidle L. A., Granneman J. G. and Bannon M. J. (1999) Characterization of the 5-flanking region of the human dopamine transporter gene. Mol. Brain Res. 74, 164-174.
19. Sacchetti P., Mitchell T. R., Granneman J. G. and Bannon M. J. (2001) Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism. J. Neurochem. 76, 1565-1572.
20. Sapetschnig A., Koch F., Rischitor G., Mennenga T. and Suske G. (2004) Complexity of translationally controlled transcription factor Sp3 isoform expression. J. Biol. Chem. 279, 42 095-42 105.
21. Suske G. (1999) The Sp-family of transcription factors. Gene 238, 291-300.
22. Wong W. K., Chen K. and Shih J. C. (2001) Regulation of human monoamine oxidase B gene by Sp1 and Sp3. Mol. Pharmacol. 59, 852-859.
23. Yang Y., Hwang C. K., Junn E., Lee G. and Mouradian M. M. (2000) Z1C2 and Sp3 repress Sp1-induced activation of the human D1A dopamine receptor gene. J. Biol. Chem. 275, 38 863-38 869.